17 Dec 2025
We are pleased to announce that the European Medicines Agency (EMA) has successfully gone live on PV Signal and PV Reports, our industry-leading platform specifically supporting signal detection, analytics, and signal validation.
With a safety database encompassing more than 35 million safety reports, EMA now operates one of the largest and advanced safety surveillance platforms powered by RxLogix technology. This implementation represents a major milestone, for EMA’s adopting next-generation tools that supports pharmacovigilance and public health across the European Union. EMA’s adoption of PV Signal and PV Reports builds upon the proven success and further raises the global benchmark for pharmacovigilance automation, analytics, data-driven intelligence and operational excellence.
This is a significant step for the pharmacovigilance office at the EMA. Supporting EMA in modernizing safety analytics is both an honour and a responsibility. This collaboration will strengthen the ability to detect and validate safety signals, ultimately supporting informed public health decisions.
RxLogix PV Signal is the industry’s most complete signal detection and management platform that provides a dynamic data mining and data analytics environment for detecting signals, uncovering patterns, and recognizing emerging trends in safety reports. RxLogix PV Reports provides a next-generation, intuitive, self-service reporting experience—supporting Canned and Ad-hoc Reports with seamless, out-of-the-box integrations and powerful visualizations.
We are extremely proud of our integrated signal detection platform being selected by the EMA, one of the world’s leading regulatory agencies, to perform safety surveillance across Europe. We aspire to be the signal detection platform of choice for regulatory agencies around the world.
Supporting Information
PV Signal –https://rxlogix.com/pv-signal/
PV Reports – https://rxlogix.com/pv-reports/
RxLogix provides the industry's best solutions to the ever-changing drug safety & pharmacovigilance
BOOK A DEMOSubscribe to our newsletter and learn the latest news from RxLogix.
Information on RxLogix Products – info@rxlogix.com
RFI and RFP Response Request – sales@rxlogix.com
Sales Inquiries – sales@rxlogix.com
Marketing Inquiries – marketing@rxlogix.com
Career Opportunities – careers@rxlogix.com
